{"title": "Commit to making an effective RSV vaccine - UGA Research News", "author": "Jennbryant", "url": "https://research.uga.edu/news/commit-to-making-an-effective-rsv-vaccine/", "hostname": "research.uga.edu", "description": "Everyone is infected by respiratory syncytial virus (RSV) by age 2. For infants, contracting RSV can be fatal. UGA's Ralph Tripp is working on a vaccine to keep babies safe and healthy.", "sitename": "University of Georgia Office of Research", "date": "2019-07-15", "cleaned_text": "Everyone is infected by respiratory syncytial virus (RSV) by age 2. For infants, contracting RSV can be fatal. UGA's Ralph Tripp is working on a vaccine to keep babies safe and healthy. Everyone is infected by respiratory syncytial virus (RSV) by age 2. For infants, contracting RSV can be fatal. UGA's Ralph Tripp is working on a vaccine to keep babies safe and healthy. "}